A syndrome of hypocalciuric hypercalcemia caused by autoantibodies directed at the calcium-sensing receptor

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 1, 2003, Pages 60-72

  Kifor, Olga ^c   Moore Jr , Francis D ^a   Delaney, Miriam ^c   Garber, Jeffrey ^b,c   Hendy, Geoffrey N ^d   Butters, Robert ^c   Gao, Ping ^e   Cantor, Thomas L ^e   Kifor, Imre ^c   Brown, Edward M ^b,c   Wysolmerski, John ^f  

^a Endocrine Hypertension Division   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d ROYAL VICTORIA HOSPITAL   (Canada)

^e Scantibodies Laboratory Inc   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CALCIUM SENSING RECEPTOR; ENDOMYSIUM ANTIBODY; GLIADIN ANTIBODY; INOSITOL PHOSPHATE; MITOGEN ACTIVATED PROTEIN KINASE; PARATHYROID HORMONE; SYNTHETIC PEPTIDE; THYROID ANTIBODY; THYROXINE;

ADULT; AMINO TERMINAL SEQUENCE; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIGEN ANTIBODY REACTION; ANTIGEN BINDING; ARTICLE; CALCIUM BLOOD LEVEL; CASE REPORT; CELL SURFACE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; ENZYME ACTIVATION; FEMALE; HASHIMOTO DISEASE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPOCALCIURIA; MUTATION; NONHUMAN; PARATHYROID CELL; PARATHYROID HORMONE RELEASE; PHENOTYPE; PRIORITY JOURNAL; WESTERN BLOTTING;

ADULT; AUTOANTIBODIES; BLOOD PHYSIOLOGY; BLOTTING, WESTERN; CALCIUM; CELL LINE; ENZYME ACTIVATION; EXTRACELLULAR SPACE; FEMALE; HUMANS; HYPERCALCEMIA; IMMUNOGLOBULINS; INOSITOL PHOSPHATES; MIDDLE AGED; MITOGEN-ACTIVATED PROTEIN KINASES; PARATHYROID GLANDS; PARATHYROID HORMONE; PEDIGREE; PEPTIDE FRAGMENTS; RECEPTORS, CALCIUM-SENSING; RECEPTORS, CELL SURFACE; SYNDROME;

ANIMALIA; BOVINAE;

EID: 0037244847     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-020249     Document Type: Article

References (51)

1. Jackson CE, Boonstra CE 1966 Hereditary Hypercalcemia and parathyroid hyperplasia without definite hyperparathyroidism. J Lab Clin Med 68:883-890
2. Foley Jr T, Harrison H, Arnaud C, Harrison H 1972 Familial benign hypercalcemia. J Pediatr 81:1060-1067
3. Marx SJ, Attie MF, Levine MA, Spiegel AM, Downs Jr RW, Lasker RD 1981 The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds. Medicine 60:397-412.
4. Law Jr WM, Heath III H 1985 Familial benign hypercalcemia (hypocalciuric hypercalcemia). Clinical and pathogenetic studies in 21 families. Ann intern Med 105:511-519
5. Brown EM 2000 Familial hypocalciuric hypercalcemia and other disorders with resistance to extracellular calcium. Endocrinol Metab Clin North Am 29:503-522
6. Heath III H 1989 Familial benign (hypocalciuric) hypercalcemia. A troublesome mimic of mild primary hyperparathyroidism. Endocrinol Metab Clin North Am 18:723-740
7. Heath DA 1994 Familial hypocalciuric hypercalcemia. In: Bilezikian JP, Marcus R, Levine MA, eds. The parathyroids. New York: Raven Press; 699-710
8. Heath III H, Odelberg S, Jackson CE, Teh BT, Hayward N, Larsson C, Buist NR, Krapcho KJ, Hung BC, Capuano IV, Garrett JE, Leppert MF 1996 Clustered inactivating mutations and benign polymorphisms of the calcium receptor gene in familial benign hypocalciuric hypercalcemia suggest receptor functional domains. J Clin Endocrinol Metab 81:1312-1317
9. Hendy GN, D'Souza-Li L, Yang B, Canaff L, Cole DE 2000 Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Hum Mutat 16:281-296
10. (2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75:1297-1303
11. Heath III H, Jackson CE, Otterud B, Leppert MF 1993 Genetic linkage analysis in familial benign (hypocalciuric) hypercalcemia: evidence for locus heterogeneity. Am J Hum Genet 53:193-200
12. Lloyd SE, Pannett AA, Dixon PH, Whyte MP, Thakker RV 1999 Localization of familial benign hypercalcemia, Oklahoma variant (FBHOk), to chromosome 19q13. Am J Hum Genet 64:189-195
13. Brown EM, MacLeod RJ 2001 Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 81:239-297
14. 2+-sensing receptor from bovine parathyroid. Nature 366:575-580
15. 2+-sensing Receptor in divalent mineral ion homeostasis. J Exp Biol 200:295-302
16. Pollak MR, Chou YH, Marx SJ, Steinmann B, Cole DE, Brandi ML, Papapoulos SE, Menko FH, Hendy GN, Brown EM, Seidman JG, Seidman CE 1994 Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype. J Clin Invest 93:1108-1112
17. Ho C, Conner DA, Pollak MR, Ladd DJ, Kifor O, Warren HB, Brown EM, Seidman JG, Seidman CE 1995 A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat Genet 11:389-394
18. Marx S, Attie M, Spiegel A, Levine M, Lasker R, Fox M 1982 An association between neonatal severe primary hyperparathyroidism and familial hypocalciuric hypercalcemia in three kindreds. N Engl J Med 306:257-284
19. (2+)-sensing receptor gene mutation. Nat Genet 8:303-307
20. Perry YM, Finegold DM, Armitage MM, Ferrell RE 1994 A missense mutation in the Ca-sensing receptor causes familial autosomal dominant hypoparathyroidism [Abstract]. Am J Hum Genet 55(Suppl):A17
21. Yamaguchi T, Chattopadhyay N, Kifor O, Ye C, Vassilev PM, Sanders JL, Brown EM 2001 Expression of extracellular calcium-sensing receptor in human osteoblastic MG-63 cell line. Am J Physiol 280:C382-C393
22. Brown EM, Hurwitz S, Aurbach GD 1976 Preparation of viable isolated bovine parathyroid cells. Endocrinology 99:1582-1588
23. 2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 81:1598-1606
24. Kifor O, Diaz R, Butters R, Kifor I, Brown EM 1998 The calcium-sensing receptor is localized in caveolin-rich plasma membrane domains of bovine parathyroid cells. J Biol Chem 273:21708-21713
25. 2, and D in bovine parathyroid and CaR-transfected, human embryonic kidney (HEK293) cells. J Bone Miner Res 12:715-725
26. o-sensing receptor. J Biol Chem 271:19537-19545
27. Brown EM, Gardner DG, Brennan MF, Marx SJ, Spiegel AM, Attie MF, Downs RWJ, Doppman JL, Aurbach GD 1977 Calcium-regulated parathyroid hormone release in primary hyperparathyroidism. Studies in vitro with dispersed parathyroid cells. Am J Med 66:923-931
28. Slatopolsky E, Finch J, Clay P, Martin D, Sicard G, Singer G, Gao P, Cantor T, Dusso A 2000 A novel mechanism for skeletal resistance in uremia. Kidney Int 58:753-761
29. Gao P, Scheibel S, D'Amour P, John MR, Rao SD, Schmidt-Gayk H, Cantor TL 2001 Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone (1-84): Implications for improvement of accurate measurement of parathyroid function. J Bone Miner Res 16:605-614
30. (2+)-sensing receptor gene in familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Am J Hum Genet 56:880-886
31. Garrett JE, Capuano IV, Hammerland LG, Hung BC, Brown EM, Hebert SC, Nemeth EF, Fuller F 1995 Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs. J Biol Chem 270:12919-12925
32. Kifor O, MacLeod RJ, Diaz R, Bai M, Yamaguchi T, Yao T, Kifor I, Brown EM 2001 Regulation of MAP kinase by calcium-sensing receptor in bovine parathyroid and CaR-transfected HEK293 cells. Am J Physiol 280:F291-F302
33. Gogusev J, Duchambon P, Hory B, Giovannini M, Goureau Y, Sarfati E, Drueke TB 1997 Depressed expression of calcium receptor in parathyroid gland tissue of patients with hyperparathyroidism. Kidney Int 51:328-336
34. Farnebo F, Enberg U, Grimelius L, Backdahl M, Schalling M, Larsson C, Farnebo LO 1997 Tumor-specific decreased expression of calcium sensing receptor messenger ribonucleic acid in sporadic primary hyperparathyroidism. J Clin Endocrinol Metab 82:3481-3486
35. Brown EM 1983 Four parameter model of the sigmoidal relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue. J Clin Endocrinol Metab 56:572-581
36. Spiegel AM 1996 Mutations in G protein and G protein-coupled receptors in endocrine disease. J Clin Endocrinol Metab 81:2434-2442
37. Tonacchera M, Van Sande J, Cetani F, Swillens S, Schvartz C, Winiszewski P, Portmann L, Dumont JE, Vassart G, Parma J 1996 Functional characterization of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic nodular thyroid hyperplasia. J Clin Endocrinol Metab 81:547-554
38. Parma J, Duprez L, va Sande JV, Cochaux P, Gervy C, Mockel J, Dumont J, Vassart G 1993 Somatic mutations in the thyrotropin receptor gene cause hyperfunctioning thyroid adenomas. Nature 365:649-651
39. Pearce SH, Trump D, Wooding C, Besser GM, Chew SL, Grant DB, Heath DA, Hughes IA, Paterson CR, Whyte MP, Thakker RV 1995 Calcium-sensing receptor mutations in familial benign hypercalcemia and neonatal hyperparathyroidism. J Clin Invest 96:2683-2692
40. Pearce SH, Williamson C, Kifor O, Bai M, Coulthard MG, Davies M, Lewis-Barned N, McCredie D, Powell H, Kendall-Taylor P, Brown EM, Thakker RV 1996 A familial syndrome of hypocalcemia with hypercalciuria due to mutations in the calcium-sensing receptor. N Engl J Med 335:1115-1122
41. (2+)-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism. Hum Mol Genet 5:601-606
42. Li Y, Song YH, Rais N, Connor E, Schatz D, Muir A, Maclaren N 1996 Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism. J Clin Invest 97:910-914
43. Veress B, Nordenstrom J 1994 Lymphocytic infiltration and destruction of parathyroid adenomas: a possible tumor-specific autoimmune reaction in two cases of parathyroid hyperparathyroidism. Histopathology 25:373-377
44. Attie MF, Gill Jr J, Stock JL, Spiegel AM, Downs Jr RW, Levine MA, Marx SJ 1983 Urinary calcium excretion in familial hypocalciuric hypercalcemia. Persistence of relative hypocalciuria after induction of hypoparathyroidism. J Clin Invest 72:667-676
45. Davies M, Adams PH, Lumb GA, Berry JL, Loveridge N 1984 Familial hypocalciuric hypercalcaemia: evidence for continued enhanced renal tubular reabsorption of calcium following total parathyroidectomy. Acta Endocrinol (Copenh) 106:499-504
46. Sands JM, Naruse M, Baum M, Jo I, Hebert SC, Brown EM, Harris HW 1997 Apical extracellular calcium/polyvalent cation-sensing receptor regulates vasopressin-elicited water permeability in rat kidney inner medullary collecting duct. J Clin Invest 99:1399-1405
47. Sands JM, Flores FX, Kato A, Baum MA, Brown EM, Ward DT, Hebert SC, Harris HW 1998 Vasopressin-elicited water and urea permeabilities are altered in IMCD in hypercalcemic rats. Am J Physiol 274:F978-F985
48. (2+)-sensing receptor in divalent mineral ion homeostasis. J Exp Biol 200:295-302
49. Marx SJ, Attie MF, Stock JL, Spiegel AM, Levine MA 1981 Maximal urine-concentrating ability: familial hypocalciuric hypercalcemia versus typical primary hyperparathyroidism. J Clin Endocrinol Metab 52:736-740
50. Silverberg SJ, Bone III HG, Marriott TB, Locker FG, Thys-Jacobs S, Dziem G, Kaatz S, Sanguinetti EL, Bilezikian JP 1997 Short-term inhibition of parathyroid hormone secretion by a calcium-receptor agonist in patients with primary hyperparathyroidism. N Engl J Med 337:1506-1510
51. Collins MT, Skarulis MC, Bilezikian JP, Silverberg SJ, Spiegel AM, Marx SJ 1998 Treatment of hypercalcemia secondary to parathyroid carcinoma with a novel calcimimetic agent. J Clin Endocrinol Metab 83:1083-1088